What it is
Wegovy injection is weekly semaglutide in a pen. It does not use the oral empty-stomach window. It is not Ozempic, not Rybelsus, and not the Wegovy pill — even when a relative calls every one of those 'Wegovy.'
Bridge and Part D
On the demonstration, approved Wegovy (pen) is $50 through 31 December 2027. No TrOOP credit. No Extra Help on that $50. A 2026 Part D GLP-1 fill generally blocks Bridge.
Covered Part D indications (T2D, moderate-to-severe OSA, MASH) belong on Part D, often under a different brand name the plan actually lists.
Other paths
Commercial-plus-card ~$25 when the plan covers the pen and the member is commercial. Manufacturer cash via NovoCare — confirm the current injection price; do not assume the pill's $149 / $199 4 mg schedule.
Telehealth bundles near $449 usually lose to cash plus a local visit.
When the pen is the practical pick
The person can inject weekly and cannot or will not keep an oral window. The clinician prefers this presentation. The pharmacy can stock the prescribed pen.
Packet language
Wegovy injection (or pen), dose, indication, dated BMI. If the family is choosing between pen and pill, say which routine they can keep.
Questions
Is the injection cheaper than the pill on Bridge?
Can I use leftover Ozempic pens?
Does Extra Help apply?
Device limits like Zepbound KwikPen?
Not sure this applies to you?
Answer a few questions and see your own numbers.
Free to see which path is likely cheapest for your coverage.
Check my options